Hiroshi Mizushima
National Institute of Public Health, Japan
Title: Standardization of Patient Registry. - Importance of Patient Registry for Evidence based Public Health.
Biography
Biography: Hiroshi Mizushima
Abstract
A New legal structure for rare disease (nambyo) has been established in Japan in 2015, after 42 years of measures of nambyo. We have been accumulating registry for nambyo from 2003, however, as it was based on paper registration, quality was not enough. We made a prototype system for online registry used for nambyo reimbursement application. We first categorized all disease, and made standard data sets. Our new registry system will be based under ISO13606 which is a medical international standard. Authorized doctors can put in data on Line by the new system, which has data cleaning filter for accurate data entry. Patients will be supported their medical expense by authorization by this system, so the registry will be efficient. We also made Offline registry system, in case of lacking online access due to security at hospitals.
As this system for nambyo was also used for pediatric rare disease registry, it was the good example for broad range of diseases. We were asked to make a guideline for Patient registries as a government funded project in 2016. We compared PARENT which is a European project, and AHRQ which is an American guideline for patient registries. There are currently no international guideline or standard for patient registry, however, to perform patient research or integrate worldwide information, which is important in the field of rare disease. We are also trying to integrate patient reported outcomes data using patient portals.
It is very important to get patient database for “Evidence based public health”, and “precision public heath”. We are trying to integrate these information for this goal.